Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials

P. D. Le Coutre, T. P. Hughes, F. X. Mahon, D. W. Kim, J. L. Steegmann, N. P. Shah, K. Gooden, N. Wallis, J. E. Cortes

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)1593-1596
Number of pages4
JournalLeukemia
Volume30
Issue number7
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Le Coutre, P. D., Hughes, T. P., Mahon, F. X., Kim, D. W., Steegmann, J. L., Shah, N. P., ... Cortes, J. E. (2016). Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials. Leukemia, 30(7), 1593-1596. https://doi.org/10.1038/leu.2015.352

Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials. / Le Coutre, P. D.; Hughes, T. P.; Mahon, F. X.; Kim, D. W.; Steegmann, J. L.; Shah, N. P.; Gooden, K.; Wallis, N.; Cortes, J. E.

In: Leukemia, Vol. 30, No. 7, 01.07.2016, p. 1593-1596.

Research output: Contribution to journalLetter

Le Coutre, PD, Hughes, TP, Mahon, FX, Kim, DW, Steegmann, JL, Shah, NP, Gooden, K, Wallis, N & Cortes, JE 2016, 'Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials', Leukemia, vol. 30, no. 7, pp. 1593-1596. https://doi.org/10.1038/leu.2015.352
Le Coutre PD, Hughes TP, Mahon FX, Kim DW, Steegmann JL, Shah NP et al. Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials. Leukemia. 2016 Jul 1;30(7):1593-1596. https://doi.org/10.1038/leu.2015.352
Le Coutre, P. D. ; Hughes, T. P. ; Mahon, F. X. ; Kim, D. W. ; Steegmann, J. L. ; Shah, N. P. ; Gooden, K. ; Wallis, N. ; Cortes, J. E. / Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials. In: Leukemia. 2016 ; Vol. 30, No. 7. pp. 1593-1596.
@article{2500b82e214a4f5fb19f320b13d6d591,
title = "Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials",
author = "{Le Coutre}, {P. D.} and Hughes, {T. P.} and Mahon, {F. X.} and Kim, {D. W.} and Steegmann, {J. L.} and Shah, {N. P.} and K. Gooden and N. Wallis and Cortes, {J. E.}",
year = "2016",
month = "7",
day = "1",
doi = "10.1038/leu.2015.352",
language = "English (US)",
volume = "30",
pages = "1593--1596",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Low incidence of peripheral arterial disease in patients receiving dasatinib in clinical trials

AU - Le Coutre, P. D.

AU - Hughes, T. P.

AU - Mahon, F. X.

AU - Kim, D. W.

AU - Steegmann, J. L.

AU - Shah, N. P.

AU - Gooden, K.

AU - Wallis, N.

AU - Cortes, J. E.

PY - 2016/7/1

Y1 - 2016/7/1

UR - http://www.scopus.com/inward/record.url?scp=84954472458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954472458&partnerID=8YFLogxK

U2 - 10.1038/leu.2015.352

DO - 10.1038/leu.2015.352

M3 - Letter

C2 - 26686247

AN - SCOPUS:84954472458

VL - 30

SP - 1593

EP - 1596

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 7

ER -